News

Adult Vaccine Market Analysis

The global adult vaccine market was valued at US$ 20.59 Billion in 2023 and is projected to reach US$ 35.87 Billion by 2032, growing at a CAGR of 6.36% from 2024 to 2032. The rising prevalence of infectious diseases such as pneumococcal illness, influenza, COVID-19, and others, combined with a growing focus on healthcare and government initiatives, is expected to fuel the demand for adult immunizations, which will drive market expansion.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Adult Vaccine Market Overview

Adult vaccines are designed to protect individuals aged 18 and above from a range of infectious diseases, reducing the risk of complications, illness, and pathogen transmission. These vaccines include both primary doses and booster shots to maintain immunity from vaccines received in childhood. Common adult vaccines include those for influenza, tetanus, diphtheria, pertussis (Tdap), pneumonia, shingles, human papillomavirus (HPV), hepatitis, and meningococcal disease.

For instance, influenza vaccines are essential every year, especially for high-risk groups like the elderly, pregnant women, and those with chronic conditions. Similarly, Tdap booster shots are advised every ten years to prevent diseases like whooping cough, diphtheria, and tetanus.

Key Data Points

• Base Year: 2023
• Forecast Years: 2024 - 2032
• Market Size in 2023: US$ 20.59 Billion
• Market Forecast in 2032: US$ 35.87 Billion
• CAGR (2024-2032): 6.36%

Key Growth Factors

1. Prevalence of Adult Diseases: As adult diseases, particularly age-related ones, become more prevalent due to longer lifespans, adults require ongoing immunizations. Diseases like pneumonia, shingles, and hepatitis are particularly at risk as the population ages.

For example, the CDC reports that influenza leads to over 75,000 hospital admissions annually in the U.S. Among older adults, Streptococcus pneumoniae remains a leading cause of death.

1. Rising Infectious Disease Rates: The spread of infectious diseases globally, including new strains and viruses, has led to a surge in adult vaccination initiatives. Governments and health agencies are working more closely with pharmaceutical companies to expand adult vaccine development and distribution.
2. Government and Healthcare Initiatives: Governments around the world, especially in North America, are expanding their vaccination programs to cover more adults and prevent diseases like pneumococcal infections and shingles.

Related Report:

Messenger RNA (mRNA) Vaccines & Therapeutics Market

United States Pain Management Therapeutics Market

Pediatric Vaccines Market

Regional Market Overview

North America

North America dominates the adult vaccine market, particularly due to rising viral infections in countries like the United States and Canada. In the U.S., the influenza vaccine alone reduces hospitalizations among older individuals by nearly 90,000 annually, underscoring the vital role of vaccination in public health. The CDC recommends various adult vaccines, including flu shots, Tdap boosters, and pneumococcal vaccines for adults aged 65 and above.

Market Players

Key players in the global adult vaccine market include:

• GlaxoSmithKline, plc.
• AstraZeneca plc
• Sanofi Pasteur
• Pfizer, Inc.
• CSL Limited

Recent Industry Developments

1. Merck announced the successful Phase 3 trial results of its V116 vaccine for pneumococcal disease in adults aged 50 and older in April 2024.
2. WHO released interim recommendations for the Pfizer-BioNTech COVID-19 vaccine in August 2022, acknowledging its safety and efficacy.

Disease-Specific Market Insights

The adult vaccine market is categorized based on diseases, including:

• Influenza
• Cervical Cancer (HPV)
• Shingles
• MMR (Measles, Mumps, Rubella)
• Pneumococcal Disease
• Meningococcal Disease
• Hepatitis
• TdaP (Tetanus, Diphtheria, Pertussis)
• Travel and Miscellaneous
• Varicella

Regional Market Breakdown

The adult vaccine market is divided into 21 countries and regions, with prominent countries such as:

• United States
• Canada
• United Kingdom
• Germany
• France
• India
• China
• Brazil
• Mexico
• Saudi Arabia
• South Africa

About Us - Renub Research

Renub Research is a premier Market Research and Advisory company with over 15 years of experience in Business-to-Business Global Market Research, Business Surveys, and Management Consulting. We provide a wide range of specialized business research services designed to help organizations make informed decisions and achieve their highest potential.

We work closely with our clients to understand the challenges they face and offer actionable insights to address these challenges. Our services are aimed at identifying the necessary changes and strategic adjustments needed for companies to succeed in today’s competitive market. Our clients include leading organizations from a wide range of industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecommunications & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.

At Renub Research, we provide our clients with detailed and accurate market data to support decision-making based on both information and knowledge. Our firm is recognized for delivering comprehensive industry solutions that aid consultants, bankers, and executives in formulating effective business strategies and making sound management decisions.

Our team comprises skilled professionals with expertise across various fields, including finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and more. The insights derived from our studies form the foundation for crucial management decisions, such as strategies, organizational structure, technology adoption, and mergers and acquisitions.

We take pride in supporting top global players, providing not only IT solutions but also comprehensive market trend analysis and opportunities. Our research reports offer critical tools for managers in today’s competitive global economy, featuring information and insights, analysis and understanding, as well as forecasts and estimations to guide decision-making